Dulce Campos

1.2k total citations
9 papers, 142 citations indexed

About

Dulce Campos is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dulce Campos has authored 9 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dulce Campos's work include Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Dulce Campos is often cited by papers focused on Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Dulce Campos collaborates with scholars based in Spain, United Kingdom and Mexico. Dulce Campos's co-authors include Vicente Villanueva, A. Molins, Rafael Toledano, Pedro Emilio Bermejo, António Gil‐Nagel, Rosa Ana Sáiz Díaz, Irene García‐Morales, José M. Serratosa, Manuel Toledo and Pedro J. Serrano‐Castro and has published in prestigious journals such as Acta Neurologica Scandinavica, Epilepsy & Behavior and Seizure.

In The Last Decade

Dulce Campos

9 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dulce Campos Spain	7	135	113	54	23	13	9	142
P. Giner Spain	5	126 0.9×	115 1.0×	51 0.9×	17 0.7×	11 0.8×	6	138
B. Vazquez United States	4	219 1.6×	224 2.0×	53 1.0×	44 1.9×	4 0.3×	6	271
Joaquín Ojeda Ruiz de Luna Spain	9	110 0.8×	97 0.9×	61 1.1×	12 0.5×	4 0.3×	14	148
B. J. Steinhoff Germany	11	274 2.0×	236 2.1×	143 2.6×	23 1.0×	6 0.5×	33	329
Luca Zagaroli Italy	6	111 0.8×	76 0.7×	53 1.0×	12 0.5×	16 1.2×	13	201
Jérémie Lefranc France	5	79 0.6×	59 0.5×	28 0.5×	10 0.4×	3 0.2×	8	141
J. Rodríguez-Uranga Spain	11	310 2.3×	263 2.3×	160 3.0×	22 1.0×	10 0.8×	16	344
G.S. Umamaheswara Rao India	7	100 0.7×	65 0.6×	63 1.2×	12 0.5×	4 0.3×	10	173
Sophie von Brauchitsch Germany	5	78 0.6×	58 0.5×	43 0.8×	5 0.2×	7 0.5×	5	119
Daniel Beaumont France	3	342 2.5×	281 2.5×	97 1.8×	35 1.5×	3 0.2×	5	378

Countries citing papers authored by Dulce Campos

Since Specialization

Citations

This map shows the geographic impact of Dulce Campos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dulce Campos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dulce Campos more than expected).

Fields of papers citing papers by Dulce Campos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dulce Campos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dulce Campos. The network helps show where Dulce Campos may publish in the future.

Co-authorship network of co-authors of Dulce Campos

This figure shows the co-authorship network connecting the top 25 collaborators of Dulce Campos. A scholar is included among the top collaborators of Dulce Campos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dulce Campos. Dulce Campos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Villanueva, Vicente, Jesús Artal, Dulce Campos, et al.. (2023). Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus. Neurology and Therapy. 12(2). 479–503. 8 indexed citations

Lawthom, Charlotte, et al.. (2019). Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study. Neurology and Therapy. 8(2). 491–504. 10 indexed citations

Giráldez, Beatriz G., Dulce Campos, Pedro J. Serrano‐Castro, et al.. (2019). Clinical outcomes of eslicarbazepine acetate monotherapy for focal‐onset seizures: A multicenter audit. Acta Neurologica Scandinavica. 140(6). 422–428. 5 indexed citations

Toledano, Rafael, Camilo Espinosa‐Jovel, Adolfo Jiménez‐Huete, et al.. (2017). Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study. Epilepsy & Behavior. 73. 173–179. 17 indexed citations

Villanueva, Vicente, Mercedes Garcés, José M. Serratosa, et al.. (2014). Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study. Clinical Drug Investigation. 35(2). 121–131. 30 indexed citations

Villanueva, Vicente, Francisco J. López, José M. Serratosa, et al.. (2013). Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide. Epilepsy & Behavior. 29(2). 349–356. 37 indexed citations

Cortijo, Elisa, Ángel L. Guerrero, Sonia Herrero, et al.. (2012). Hemicrania continua in a headache clinic: referral source and diagnostic delay in a series of 22 patients. The Journal of Headache and Pain. 13(7). 567–569. 13 indexed citations

García‐Morales, Irene, et al.. (2011). Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures. Seizure. 20(10). 801–804. 18 indexed citations

Mateos, V, et al.. (1995). [Recurrent confusional states and periodic lateralized epileptiform discharges: a new type of non-convulsive status epilepticus?].. PubMed. 10(7). 298–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact